Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Horizon Therapeutics Public Ltd Co | EVP, Chief Financial Officer | Ordinary Shares | 0 | $116.50 | Oct 6, 2023 | Direct | |
Horizon Therapeutics Public Ltd Co | EVP, Chief Financial Officer | Performance Restricted Stock Units | 0 | Oct 6, 2023 | Direct | ||
Horizon Therapeutics Public Ltd Co | EVP, Chief Financial Officer | Restricted Stock Units | 0 | Oct 6, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
HZNP | Horizon Therapeutics Public Ltd Co | Oct 6, 2023 | 13 | -$64.8K | 4 | Oct 6, 2023 | EVP, Chief Financial Officer |
HZNP | Horizon Therapeutics Public Ltd Co | Jan 13, 2023 | 1 | -$4.09M | 4 | Jan 17, 2023 | EVP, Chief Financial Officer |
HZNP | Horizon Therapeutics Public Ltd Co | Jan 4, 2023 | 1 | $0 | 4 | Jan 6, 2023 | EVP, Chief Financial Officer |
HZNP | Horizon Therapeutics Public Ltd Co | Dec 30, 2022 | 10 | -$3.27M | 4 | Jan 4, 2023 | EVP, Chief Financial Officer |
HZNP | Horizon Therapeutics Public Ltd Co | Dec 27, 2022 | 4 | $0 | 4 | Dec 29, 2022 | EVP, Chief Financial Officer |
HZNP | Horizon Therapeutics Public Ltd Co | May 16, 2022 | 0 | $0 | 3 | May 16, 2022 | EVP, Chief Financial Officer |